Ceftriaxone and metronidazole for cholecystitis

o Ceftriaxone 2g IV q24h metronidazole 500mg PO/IV q8h. Alternate regimen for acute calculous cholecystitis: a randomized clinical trial. JAMA

▫ No cholelithiasis in 20% (acalculous) → Acalculous cholecystitis ▫ IV ATB (Ceftriaxone Metronidazole). ▫ Fluid resusitation. ▫ Treatment

cholecystitis or acute biliary tract infections which may not be ime and metronidazole,971 ceftriaxone and metronidazole,980 cefotaxime and

regardless of age. ➢ For mild to moderate acute cholecystitis, perioperative cefazolin, cefoxitin, or ceftriaxone are appropriate surgical

The empirical regime of ceftriaxone and metronidazole remains appropriate for intra-abdominal infection secondary to appendicitis and cholecystitis. In cases involving perforated small and large bowel, including complicated sigmoid diverticulitis, the judicious use of ceftriaxone and metronidazole i

Ceftriaxone and metronidazole remain as appropriate empirical therapy for patients who presented with perforated appendicitis and cholecystitis.

Once-daily ceftriaxone plus metronidazole versus ertapenem and/or cefoxitin for pediatric appendicitis. Treatment of acute calculous cholecystitis.

the Metronidazole was not only used in grade III (61%) patients but it cholecystitis. In grade III acute cholecystitis as irritation is a obstacle

cholecystitis in high-risk The concentration should not exceed 5 to 7.5 mg/mL metronidazole hydrochloride with ceftriaxone 10 mg/mL as an admixture.